retatrutide phase 3 results The TRIUMPH-1 just dropped on retatrutide. Here is what the numbers actually say. is a triple agonist. It targets GLP-1, GIP, and glucagon receptors. Ozempic targets one. Mounjaro The data just dropped —

Coverage evolves, with various states and plans differing in offered benefits

Elevated cortisol promotes visceral fat storage, increases water retention, impairs muscle recovery, and can trigger emotional eating patterns that the medication only partially counteracts

Turns out my estrogen was way too low

In SURMOUNT-OSA 1, participants receiving tirzepatide 15 mg experienced mean AHI reductions of 27.4 events per hour from baseline, compared to 4.8 events per hour with placebo

Guidelines for withholding these agents before procedures remain inconsistent

Most patients experience appetite rebound to baseline or slightly higher within 48 weeks